 | SCYNEXIS (SCYX) Releases Quarterly Earnings Results
www.americanbankingnews.com - November 14 at 12:16 PM |
 | SCYNEXIS, Inc.
www.streetinsider.com - November 14 at 8:13 AM |
 | SCYNEXIS beats by $0.15, misses on revenue
seekingalpha.com - November 13 at 5:14 PM |
 | Scynexis: 3Q Earnings Snapshot
finance.yahoo.com - November 13 at 5:14 PM |
| SCYNEXIS Reports Third Quarter 2018 Financial Results and Provides Company Update
finance.yahoo.com - November 13 at 5:14 PM |
| Scynexis (SCYX) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 13 at 5:14 PM |
| SCYNEXIS (SCYX) Given a $4.00 Price Target at Maxim Group
www.americanbankingnews.com - November 13 at 1:27 PM |
 | Will Scynexis (SCYX) Report Negative Earnings Next Week? What You Should Know
www.zacks.com - October 31 at 8:15 AM |
| SCYNEXIS Inc (SCYX) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - October 27 at 2:40 AM |
| SCYNEXIS Announces FDA Agreement with Company-Proposed Phase 3 Vulvovaginal Candidiasis Program for Oral Ibrexafungerp
finance.yahoo.com - October 23 at 5:08 PM |
| HC Wainwright Analysts Give SCYNEXIS (SCYX) a $5.00 Price Target
www.americanbankingnews.com - October 23 at 2:56 PM |
 | SCYNEXIS, Inc. Announces First Patient Dosed in Phase 3 Open-label Study Evaluating Oral Ibrexafungerp in Candida ...
www.prnewswire.com - October 17 at 5:01 PM |
| SCYNEXIS, Inc. Announces First Patient Dosed in Phase 3 Open-label Study Evaluating Oral Ibrexafungerp in Candida auris Infections (CARES)
finance.yahoo.com - October 15 at 5:09 PM |
| SCYNEXIS Supports AMR Challenge and Fungal Disease Awareness Week
finance.yahoo.com - October 1 at 4:59 PM |
| SCYNEXIS to Present an Overview of the Company's Pipeline at IDWeek 2018
finance.yahoo.com - September 26 at 8:20 AM |
| SCYNEXIS, Inc. to Present at Upcoming Investor Conferences
finance.yahoo.com - September 25 at 8:12 AM |
| Who Owns SCYNEXIS Inc (NASDAQ:SCYX)?
finance.yahoo.com - September 18 at 5:01 PM |
| SCYNEXIS, Inc. to Participate in Upcoming Investor Conferences
finance.yahoo.com - August 29 at 8:23 AM |
| SCYNEXIS misses by $0.06, misses on revenue
seekingalpha.com - August 10 at 8:15 AM |
| Scynexis (SCYX) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 10 at 8:15 AM |
| Scynexis: 2Q Earnings Snapshot
finance.yahoo.com - August 9 at 6:08 PM |
| SCYNEXIS Reports Second Quarter 2018 Financial Results and Provides Company Update
finance.yahoo.com - August 9 at 6:08 PM |
| The World Health Organization Recognizes New Antifungal Class by Granting "ibrexafungerp" to SCYNEXIS as the International Non-Proprietary Name for SCY-078
finance.yahoo.com - July 18 at 4:53 PM |
 | Week Ahead In Pharmaceuticals - 7 Stocks To Watch
www.nasdaq.com - July 14 at 3:39 PM |
| SCYNEXIS: An Update On This ~$2 'Lottery Ticket'
seekingalpha.com - July 14 at 3:39 PM |
| Why Scynexis Stock Rose 16.4% Yesterday
finance.yahoo.com - July 12 at 4:49 PM |
| Biotech Analysis Central Pharma News: Pfizer's Unit Separation, BioCryst's Merger Collapses, Scynexis' Positive Mid-Stage Results
seekingalpha.com - July 12 at 8:15 AM |
| SCYNEXIS selects dose regimen for late-stage studies of antifungal SCY-078
seekingalpha.com - July 11 at 8:12 AM |
| Scynexis (SCYX) Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in VVC
www.streetinsider.com - July 10 at 5:00 PM |
| SCYNEXIS Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in Vulvovaginal Candidiasis
finance.yahoo.com - July 10 at 5:00 PM |
| Complimentary Technical Snapshots on Mylan and Three More Generic Drugs Stocks
finance.yahoo.com - July 2 at 8:23 AM |
| SCYNEXIS Announces the Presentation of SCY-078 Data at the Teratology Society 58th Annual Meeting
finance.yahoo.com - June 27 at 8:48 AM |
| Scynexis, Undervalued And Filling A Critical Need In The Antifungal Space
seekingalpha.com - June 26 at 5:20 PM |
| Form 8-K SCYNEXIS INC For: Jun 14
www.streetinsider.com - June 22 at 5:45 PM |
| SCYNEXIS to Present SCY-078 Data at Three Scientific Meetings in June/July 2018
finance.yahoo.com - June 14 at 8:18 AM |
| SCYNEXIS Presents SCY-078 Data at ASM Microbe 2018
finance.yahoo.com - June 11 at 5:14 PM |
| Your Daily Pharma Scoop: Scynexis Moves Up, Proteostasis Disappoints Investors, Cellectar Zooms
seekingalpha.com - June 11 at 8:12 AM |
| SCYNEXIS announces publication of early-stage SCY-078 data; shares up 2% premarket
seekingalpha.com - June 6 at 5:31 PM |
| SCYNEXIS to Present SCY-078 Data at ASM Microbe 2018
finance.yahoo.com - May 24 at 5:46 PM |
| Free Daily Technical Summary Reports on Mylan and Three Other Generic Drugs Stocks
finance.yahoo.com - May 24 at 8:15 AM |
| SCYNEXIS to Participate in a Panel at the 2018 BIO International Convention
finance.yahoo.com - May 23 at 5:40 PM |
| What’s Behind the 28% Hike in SCYNEXIS Stock Last Week?
finance.yahoo.com - May 22 at 8:16 AM |
| SCYNEXIS beats by $0.08, misses on revenue
seekingalpha.com - May 9 at 8:15 AM |
| Scynexis: 1Q Earnings Snapshot
finance.yahoo.com - May 9 at 8:14 AM |
| SCYNEXIS Reports First Quarter 2018 Financial Results and Provides Company Update
finance.yahoo.com - May 8 at 5:45 PM |
| Roth Capital Assumes SCYNEXIS (SCYX) at Buy
www.streetinsider.com - May 8 at 8:12 AM |
 | Benzinga's Top Upgrades, Downgrades For May 7, 2018
www.benzinga.com - May 7 at 5:43 PM |
| UPDATE: HC Wainwright Starts SCYNEXIS (SCYX) at Buy
www.streetinsider.com - May 7 at 8:15 AM |
| Scynexis (SCYX) Granted FDA Fast Track & Qualified Infectious Disease Product Designation for Oral SCY-078
www.streetinsider.com - May 2 at 8:17 AM |
| SCYNEXIS's Oral SCY-078 Receives FDA QIDP and Fast Track Designations for the Treatment of VVC and Prevention ...
www.prnewswire.com - May 1 at 5:21 PM |
